GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Piotroski F-Score

Lexagene Holdings (Lexagene Holdings) Piotroski F-Score : 0 (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lexagene Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Lexagene Holdings's Piotroski F-Score or its related term are showing as below:


Lexagene Holdings Piotroski F-Score Historical Data

The historical data trend for Lexagene Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Piotroski F-Score Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 2.00 6.00 3.00

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.00 3.00 3.00 2.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Nov22) TTM:Last Year (Nov21) TTM:
Net Income was -2.309 + -2.111 + -2.077 + -1.678 = $-8.18 Mil.
Cash Flow from Operations was -1.837 + -1.797 + -1.637 + -1.63 = $-6.90 Mil.
Revenue was -0.014 + 0.015 + 0.061 + 0.043 = $0.11 Mil.
Gross Profit was -0.179 + -0.141 + -0.187 + -0.147 = $-0.65 Mil.
Average Total Assets from the begining of this year (Nov21)
to the end of this year (Nov22) was
(5.362 + 8.198 + 6.131 + 4.195 + 3.49) / 5 = $5.4752 Mil.
Total Assets at the begining of this year (Nov21) was $5.36 Mil.
Long-Term Debt & Capital Lease Obligation was $0.56 Mil.
Total Current Assets was $2.30 Mil.
Total Current Liabilities was $1.66 Mil.
Net Income was -2.357 + -2.712 + -2.816 + -2.692 = $-10.58 Mil.

Revenue was 0.058 + 0 + 0.041 + 0.048 = $0.15 Mil.
Gross Profit was -0.101 + -0.095 + -0.091 + -0.1 = $-0.39 Mil.
Average Total Assets from the begining of last year (Nov20)
to the end of last year (Nov21) was
(12.259 + 13.195 + 10.482 + 8.059 + 5.362) / 5 = $9.8714 Mil.
Total Assets at the begining of last year (Nov20) was $12.26 Mil.
Long-Term Debt & Capital Lease Obligation was $0.93 Mil.
Total Current Assets was $3.66 Mil.
Total Current Liabilities was $0.68 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lexagene Holdings's current Net Income (TTM) was -8.18. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lexagene Holdings's current Cash Flow from Operations (TTM) was -6.90. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Nov21)
=-8.175/5.362
=-1.52461768

ROA (Last Year)=Net Income/Total Assets (Nov20)
=-10.577/12.259
=-0.86279468

Lexagene Holdings's return on assets of this year was -1.52461768. Lexagene Holdings's return on assets of last year was -0.86279468. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Lexagene Holdings's current Net Income (TTM) was -8.18. Lexagene Holdings's current Cash Flow from Operations (TTM) was -6.90. ==> -6.90 > -8.18 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Nov22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Nov21 to Nov22
=0.561/5.4752
=0.10246201

Gearing (Last Year: Nov21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Nov20 to Nov21
=0.926/9.8714
=0.09380635

Lexagene Holdings's gearing of this year was 0.10246201. Lexagene Holdings's gearing of last year was 0.09380635. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Nov22)=Total Current Assets/Total Current Liabilities
=2.296/1.655
=1.38731118

Current Ratio (Last Year: Nov21)=Total Current Assets/Total Current Liabilities
=3.658/0.68
=5.37941176

Lexagene Holdings's current ratio of this year was 1.38731118. Lexagene Holdings's current ratio of last year was 5.37941176. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Lexagene Holdings's number of shares in issue this year was 139.009. Lexagene Holdings's number of shares in issue last year was 119.23. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-0.654/0.105
=-6.22857143

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-0.387/0.147
=-2.63265306

Lexagene Holdings's gross margin of this year was -6.22857143. Lexagene Holdings's gross margin of last year was -2.63265306. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Nov21)
=0.105/5.362
=0.01958225

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Nov20)
=0.147/12.259
=0.01199119

Lexagene Holdings's asset turnover of this year was 0.01958225. Lexagene Holdings's asset turnover of last year was 0.01199119. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lexagene Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Lexagene Holdings  (OTCPK:LXXGQ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Lexagene Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.